Back to Search
JAY PEPOSE, M.D.
M.D.
Specialist
NPI: 1134111446IndividualAccepts Medicare
Education
OTHER
Class of 1982
Clinical Trials (2)
2
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study.
PMID 27055211·Cornea·2016
3-trial
Lifitegrast clinical efficacy for treatment of signs and symptoms of dry eye disease across three randomized controlled trials.
PMID 27388660·Curr Med Res Opin·2016
8-other
Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management.
PMID 22475641·Cornea·2012
4-observational
Comparison of contrast sensitivity, depth of field and ocular wavefront aberrations in eyes with an IOL with zero versus positive spherical aberration.
PMID 19277694·Graefes Arch Clin Exp Ophthalmol·2009
4-observational
Maximizing satisfaction with presbyopia-correcting intraocular lenses: the missing links.
PMID 18789794·Am J Ophthalmol·2008
6-review
Changes in corneal biomechanics and intraocular pressure following LASIK using static, dynamic, and noncontact tonometry.
PMID 17188041·Am J Ophthalmol·2007
3-trial
Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy.
PMID 16490506·Am J Ophthalmol·2006
6-review
Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice.
PMID 12237416·J Gen Virol·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1815 CLARKSON RD
CHESTERFIELD, MO 63017 - Phone
- (636) 728-0111
Quick Facts
- NPI
- 1134111446
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile